Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent

UnknownOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2021

Conditions
Ischemic Heart Disease
Interventions
DEVICE

BioMimeTM Stent, Ultimaster® Stent

Trial Locations (1)

135-710

RECRUITING

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Meril Life Sciences Pvt. Ltd.

INDUSTRY

collaborator

Terumo Corporation

INDUSTRY

lead

Hyeon-Cheol Gwon

OTHER

NCT02986295 - Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent | Biotech Hunter | Biotech Hunter